Get startedLog in
    Picture of Sangamo Therapeutics logo

    SGMOQ — Sangamo Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Sangamo Therapeutics Q3 Operating Income USD 10.631 Million

    Picture of Sangamo Therapeutics logoSangamo Therapeutics
    12/11/2024 21:01
    Nov 12 (Reuters) - Sangamo Therapeutics Q3 operating expenses USD 38.8
million.
* Q3 revenue USD 49.412 million vs. IBES estimate USD 17.9 million
* Q3 net income USD 10.672 million
* Q3 adjusted operating expenses USD 34.2 million

    Recent news on Sangamo Therapeutics

    See all news